ADTX
Aditxt, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−11.54%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$24.4B
- Revenue estimate
- $1.0M
Latest reported
- Last report date
- May 20, 2026
- EPS actual
- -$2.06
- EPS estimate
- -$2.2B
- Revenue actual
- —
- Revenue estimate
- $1.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +35.6%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 20, 2026 | -$2.2B | -$2.06 | Beat 100.00% | — |
| Nov 17, 2025 | — | -$73 | — | $748 |
| Aug 14, 2025 | — | -$392 | — | $1.0K |
| May 15, 2025 | — | -$8.12 | — | $1.0K |
| Mar 24, 2025 | -$26.4K | -$101 | Beat 99.62% | — |
| Nov 18, 2024 | -$27.4K | -$27.8K | Miss -1.34% | — |
| Aug 19, 2024 | -$26.9K | -$41.9K | Miss -55.76% | $44.3K |
| May 20, 2024 | -$33.3K | -$91.4K | Miss -174.47% | $79.7K |
| Nov 14, 2023 | -$59.9K | -$487.7K | Miss -714.19% | $124.5K |
| Aug 14, 2023 | -$1.2M | -$368.0K | Beat 68.17% | $221.0K |
| May 15, 2023 | -$2.78 | -$1.31 | Beat 52.88% | $218.4K |
| Nov 14, 2022 | -$1000.0K | -$2.1M | Miss -110.80% | $323.1K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026